Intelligent Bio Solutions Reports Unregistered Equity Sales
Ticker: INBS · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1725430
Sentiment: neutral
Topics: unregistered-sales, equity-securities, filing
TL;DR
Intelligent Bio Solutions sold unregistered equity, potentially diluting shares.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on November 28, 2025, reporting unregistered sales of equity securities on November 25, 2025. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal executive offices in New York City.
Why It Matters
This filing indicates the company has issued new equity without a prior registration, which could impact existing shareholders through dilution or signal a need for capital.
Risk Assessment
Risk Level: medium — Unregistered sales can signal financial distress or lead to dilution, increasing risk for existing investors.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- November 25, 2025 (date) — Date of earliest event reported
- November 28, 2025 (date) — Filing date
- 135 West 41st Street, 5th Floor New York, NY 10036 (address) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities in the provided text.
Were these sales to accredited investors?
The filing mentions 'Unregistered Sales of Equity Securities' but does not provide details on the purchasers or their accreditation status in the provided text.
What was the aggregate dollar amount of the unregistered sales?
The provided text for the 8-K filing does not specify the aggregate dollar amount of the unregistered sales.
What is the purpose of these unregistered sales?
The filing does not disclose the specific purpose for the unregistered sales of equity securities in the provided text.
When was Intelligent Bio Solutions Inc. formerly known as GBS Inc.?
The company's name change from GBS Inc. to Intelligent Bio Solutions Inc. occurred on September 19, 2019.
Filing Stats: 466 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-11-28 17:00:45
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 33KB
- 0001493152-25-025410.txt ( ) — 197KB
- inbs-20251125.xsd (EX-101.SCH) — 3KB
- inbs-20251125_lab.xml (EX-101.LAB) — 33KB
- inbs-20251125_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 28, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer